miR-132 serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell viability
Abstract Background Gestational diabetes mellitus (GDM) leads to poor pregnancy outcomes. Strategies that improve trophoblast cell function are important methods for GDM treatment. This study aimed to investigate the expression and diagnostic potential of microRNA-132 (miR-132) in GDM patients, and...
Saved in:
Main Authors: | Xuegui Zhou (Author), Cuiping Xiang (Author), Xiaoxia Zheng (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System
by: Kaizu Xu, et al.
Published: (2021) -
Advances in Roles of miR-132 in the Nervous System
by: Yun Qian, et al.
Published: (2017) -
Silence of miR-32-5p promotes endothelial cell viability by targeting KLF2 and serves as a diagnostic biomarker of acute myocardial infarction
by: Yunxiang Dai, et al.
Published: (2020) -
Effect of miR-132 on bupivacaine-induced neurotoxicity in human neuroblastoma cell line
by: Huiying Zhang, et al.
Published: (2019) -
Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain
by: Masashi Fukuoka, et al.
Published: (2018)